Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Suspended 1 Completed 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Thrombosis 1 Lymphoma, Follicular 1 Ischemic Stroke 1

Interventions

Cyclophosphamide 1492 Cisplatin 1413 Paclitaxel 1316 Radiotherapy 1261 Carboplatin 1249 Gemcitabine 1215 Docetaxel 1109 Bevacizumab 1030 Fluorouracil 894 Doxorubicin 792 Dexamethasone 748 Rituximab 719 Capecitabine 716 Oxaliplatin 700 Etoposide 678 pembrolizumab 677 Irinotecan 634 Filgrastim 621 Cytarabine 586 Leucovorin 579 Nivolumab 558 Vincristine 515 Prednisone 475 Cetuximab 465 Bortezomib 459 Erlotinib Hydrochloride 456 Trastuzumab 447 Methotrexate 438 Lenalidomide 427 Pemetrexed 419

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Interventional × Anticoagulants × Clear all

NCT05507645 2024-09-05

PUMICE

Beijing Tiantan Hospital

Phase 3 Completed

Ischemic Stroke, Lymphoma, Follicular, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡